Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ampicillin Pivaloyl Ester
2. Berocillin
3. Ester, Ampicillin Pivaloyl
4. Hydrochloride, Pivampicillin
5. Monohydrochloride, Pivampicillin
6. Pivamiser
7. Pivampicillin Hydrochloride
8. Pivampicillin Monohydrochloride
9. Pondocillin
1. Pivaloylampicillin
2. 33817-20-8
3. Pivaloyloxymethyl Ampicillinate
4. Pivampicilina
5. Pivampicilline
6. Pivampicillinum
7. Ampicillin Pivaloyloxymethyl Ester
8. Pivampicilina [inn-spanish]
9. Pivampicilline [inn-french]
10. Pivampicillinum [inn-latin]
11. Pivampicillin (inn)
12. 0hlm346ll7
13. Chebi:8255
14. 2,2-dimethylpropanoyloxymethyl (2s,5r,6r)-6-[[(2r)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
15. Mk-191
16. Pivampicillin [inn]
17. Dsstox_cid_25459
18. Dsstox_rid_80890
19. Dsstox_gsid_45459
20. 2,2-dimethylpropanoyloxymethyl (2s,5r,6r)-6-[(2-amino-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
21. Pivampicillin [inn:ban]
22. Mk 191
23. Pondocillin (tn)
24. Einecs 251-688-6
25. Unii-0hlm346ll7
26. Ncgc00016823-01
27. Cas-33817-20-8
28. Prestwick0_001009
29. Prestwick1_001009
30. Prestwick2_001009
31. Prestwick3_001009
32. Pivampicillin [mi]
33. Schembl34182
34. Bspbio_001137
35. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (2s-(2alpha,5alpha,6beta(s*)))-
36. Pivampicillin [mart.]
37. Spbio_003018
38. Pivampicillin [who-dd]
39. Bpbio1_001251
40. Chembl3182343
41. Dtxsid1045459
42. Hms1571i19
43. Hms2098i19
44. Hms3715i19
45. Pivampicillin [ep Monograph]
46. Tox21_110631
47. Zinc34967244
48. Tox21_110631_1
49. Ccg-221009
50. Db01604
51. Ncgc00179290-01
52. Ncgc00179290-03
53. [(2,2-dimethylpropanoyl)oxy]methyl 6beta-[(2r)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylate
54. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-, Hydroxymethyl Ester, Pivalate (ester), D-(-)-
55. Ab00513999
56. D08396
57. Sr-01000872693
58. Q3122143
59. Sr-01000872693-1
60. (2s,5r,6r)-pivaloyloxymethyl 6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
61. {[(2s,5r,6r)-6-[(2r)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-yl]carbonyloxy}methyl 2,2-dimethylpropanoate
62. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester (2s-(2.alpha.,5.alpha.,6.beta.(s*)))-
63. Hydroxymethyl D-(-)-6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate Pivalate (ester)
| Molecular Weight | 463.5 g/mol |
|---|---|
| Molecular Formula | C22H29N3O6S |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 9 |
| Exact Mass | 463.17770683 g/mol |
| Monoisotopic Mass | 463.17770683 g/mol |
| Topological Polar Surface Area | 153 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 774 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
or the treatment of respiratory tract infections (including acute bronchitis, acute exacerbations of chronic bronchitis and pneumonia); ear, nose and throat infections; gynecological infections; urinary tract infections (including acute uncomplicated gonococcal urethritis) when caused by non penicillinase-producing susceptible strains of the following organisms: gram-positive organisms, e.g., streptococci, pneumococci and staphylococci; gram-negative organisms, e.g., H. influenzae, N. gonorrhoeae, E. coli, P. mirabilis.
Pivampicillin is the pivaloyloxymethyl ester of (the semi-synthetic penicillin) ampicillin. It is an inactive pro-drug, which is converted during its absorption from the gastrointestinal tract to the microbiologically active ampicillin, together with formaldehyde and pivalic acid, by non-specific esterases present in most body tissues. Amounts in excess of 99% of the pivampicillin absorbed are converted to ampicillin within 15 minutes of absorption.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01C - Beta-lactam antibacterials, penicillins
J01CA - Penicillins with extended spectrum
J01CA02 - Pivampicillin
Absorption
Absorbed following oral administration.
Approximately 1 hour.
Ampicillin (the active metabolite of pivampicillin) has a bactericidal action resulting from inhibition of cell wall mucopeptide biosynthesis.
Digital Content 
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Pivampicillin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pivampicillin, including repackagers and relabelers. The FDA regulates Pivampicillin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pivampicillin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pivampicillin supplier is an individual or a company that provides Pivampicillin active pharmaceutical ingredient (API) or Pivampicillin finished formulations upon request. The Pivampicillin suppliers may include Pivampicillin API manufacturers, exporters, distributors and traders.
click here to find a list of Pivampicillin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pivampicillin CEP of the European Pharmacopoeia monograph is often referred to as a Pivampicillin Certificate of Suitability (COS). The purpose of a Pivampicillin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pivampicillin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pivampicillin to their clients by showing that a Pivampicillin CEP has been issued for it. The manufacturer submits a Pivampicillin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pivampicillin CEP holder for the record. Additionally, the data presented in the Pivampicillin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pivampicillin DMF.
A Pivampicillin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pivampicillin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pivampicillin suppliers with CEP (COS) on PharmaCompass.
Pivampicillin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pivampicillin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pivampicillin GMP manufacturer or Pivampicillin GMP API supplier for your needs.
A Pivampicillin CoA (Certificate of Analysis) is a formal document that attests to Pivampicillin's compliance with Pivampicillin specifications and serves as a tool for batch-level quality control.
Pivampicillin CoA mostly includes findings from lab analyses of a specific batch. For each Pivampicillin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pivampicillin may be tested according to a variety of international standards, such as European Pharmacopoeia (Pivampicillin EP), Pivampicillin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pivampicillin USP).
LOOKING FOR A SUPPLIER?
